Editas Medicine, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
EDIT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
11 Hurley St., Cambridge, MA

Insiders trading volume in the past year

Editas Medicine, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michelle Robertson Evp, Chief Financial Officer $1.16M May 11, 2023
Bruce Eaton Evp, Cbo And Cto $815K Dec 5, 2023
Mark Shearman Evp, Chief Scientific Officer $714K Feb 13, 2023
Gilmore O'Neill CEO, Director $579K -$81.2K -12.3% Dec 3, 2025
Baisong Mei Evp, Chief Medical Officer $277K Dec 3, 2024
Lisa Michaels EVP/Chief Medical Officer $247K Dec 22, 2021
Erick Lucera Evp, Chief Financial Officer $193K -$7.03K -3.52% Mar 8, 2025
Linda Burkly Evp, Chief Scientific Officer $148K -$22.3K -13.1% Dec 3, 2025
Amy Parison SVP, Chief Financial Officer $34.3K -$4.7K -12.1% Dec 3, 2025
Emma Reeve Director May 30, 2024
Meeta Chatterjee Director May 30, 2024
David Scadden Director Jun 6, 2025
Akshay Vaishnaw Director May 30, 2024
Mullen James C CEO, Director Apr 14, 2022
Bernadette Connaughton Director Jun 6, 2025
Andrew Hirsch Director Jun 6, 2025
Elliott Levy Director Jun 6, 2025
Jessica Hopfield Director Jun 6, 2025

Recent Insider Transactions by Companies or Individuals for Editas Medicine, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.